Institut Català de la Salut
[Naamneh Elzenaty R, Naamneh Elzenaty C] Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Department of BioMedical Research, University of Bern, Bern, Switzerland. Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland. [Martinez de Lapiscina I] Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Department of BioMedical Research, University of Bern, Bern, Switzerland. Biobizkaia Health Research Institute, Cruces University Hospital, University of the Basque, Barakaldo, Spain. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. Endo-ERN, HV Amsterdam, The Netherlands. [Sauter KS] Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Department of BioMedical Research, University of Bern, Bern, Switzerland. [Moreno F] Department of Pediatrics, Hospital Infantil La Fe, Valencia, Spain. [Camats-Tarruella N] Grup de Recerca de Creixement i Desenvolupament, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2024-11-06T12:24:19Z
2024-11-06T12:24:19Z
2024-09-20
Androgen receptor; Disorders of sex development; Steroidogenic factor 1
Receptor de andrógenos; Trastornos del desarrollo sexual; Factor esteroidogénico 1
Receptor d'andrògens; Trastorns del desenvolupament sexual; Factor esteroidogènic 1
Steroidogenic factor 1 (SF-1) is a nuclear receptor that regulates steroidogenesis and reproductive development. NR5A1/SF-1 variants are associated with a broad spectrum of phenotypes across individuals with disorders of sex development (DSDs). Oligogenic inheritance has been suggested as an explanation. SF-1 interacts with numerous partners. Here, we investigated a constellation of gene variants identified in a 46,XY severely undervirilized individual carrying an ACMG-categorized 'pathogenic' NR5A1/SF-1 variant in comparison to the healthy carrier father. Candidate genes were revealed by whole exome sequencing, and pathogenicity was predicted by different in silico tools. We found variants in NR1H2 and INHA associated with steroidogenesis, sex development, and reproduction. The identified variants were tested in cell models. Novel SF-1 and NR1H2 binding sites in the AR and INHA gene promoters were found. Transactivation studies showed that wild-type NR5A1/SF-1 regulates INHA and AR gene expression, while the NR5A1/SF-1 variant had decreased transcriptional activity. NR1H2 was found to regulate AR gene transcription; however, the NR1H2 variant showed normal activity. This study expands the NR5A1/SF-1 network of interacting partners, while not solving the exact interplay of different variants that might be involved in revealing the observed DSD phenotype. It also illustrates that understanding complex genetics in DSDs is challenging.
This study was supported by a project grant from the Swiss National Science Foundation (320030-197725). I.M.d.L. is supported by a Postdoctoral Fellowship Grant from the Education Department of the Basque Government (Spain) (POS_2020_1_0034).
Article
Published version
English
Diferenciació sexual - Trastorns; Hormones esteroides - Receptors; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Receptors, Steroid::Receptors, Androgen; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Receptors, Cytoplasmic and Nuclear::Steroidogenic Factor 1; DISEASES::Endocrine System Diseases::Gonadal Disorders::Disorders of Sex Development; Other subheadings::Other subheadings::Other subheadings::/genetics; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::receptores citoplásmicos y nucleares::receptores de esteroides::receptores de andrógenos; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::receptores citoplásmicos y nucleares::factor 1 esteroidogénico; ENFERMEDADES::enfermedades del sistema endocrino::trastornos gonadales::trastornos del desarrollo sexual; Otros calificadores::Otros calificadores::Otros calificadores::/genética
MDPI
International Journal of Molecular Sciences;25(18)
https://doi.org/10.3390/ijms251810109
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]